A detailed history of Ingalls & Snyder LLC transactions in Pfizer Inc stock. As of the latest transaction made, Ingalls & Snyder LLC holds 59,100 shares of PFE stock, worth $1.65 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
59,100
Previous 26,100 126.44%
Holding current value
$1.65 Million
Previous $751,000 118.38%
% of portfolio
0.07%
Previous 0.03%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$25.89 - $29.73 $1.19 Million - $1.37 Million
46,130 Added 8.0%
622,932 $17.3 Million
Q4 2023

Jan 29, 2024

SELL
$26.13 - $33.94 $678,099 - $880,776
-25,951 Reduced 4.31%
576,802 $16.6 Million
Q3 2023

Nov 02, 2023

BUY
$32.09 - $37.51 $131,665 - $153,903
4,103 Added 0.69%
602,753 $20 Million
Q2 2023

Jul 27, 2023

BUY
$36.12 - $41.79 $25,934 - $30,005
718 Added 0.12%
598,650 $22 Million
Q1 2023

May 09, 2023

BUY
$39.39 - $51.28 $659,270 - $858,273
16,737 Added 2.88%
597,932 $24.4 Million
Q4 2022

Jan 31, 2023

SELL
$41.75 - $54.5 $2,463 - $3,215
-59 Reduced 0.01%
581,195 $29.8 Million
Q3 2022

Oct 21, 2022

SELL
$43.76 - $53.42 $54,393 - $66,401
-1,243 Reduced 0.21%
581,254 $25.4 Million
Q2 2022

Aug 11, 2022

SELL
$46.53 - $55.17 $95,200 - $112,877
-2,046 Reduced 0.35%
582,497 $30.5 Million
Q1 2022

May 09, 2022

BUY
$45.75 - $56.69 $220,881 - $273,699
4,828 Added 0.83%
584,543 $30.3 Million
Q4 2021

Feb 11, 2022

BUY
$41.32 - $61.25 $114,291 - $169,417
2,766 Added 0.48%
579,715 $34.2 Million
Q3 2021

Oct 27, 2021

SELL
$39.25 - $50.42 $763,412 - $980,669
-19,450 Reduced 3.26%
576,949 $24.8 Million
Q2 2021

Aug 03, 2021

SELL
$35.91 - $40.68 $200,593 - $227,238
-5,586 Reduced 0.93%
596,399 $23.4 Million
Q1 2021

Apr 21, 2021

SELL
$33.49 - $37.77 $246,854 - $278,402
-7,371 Reduced 1.21%
601,985 $21.8 Million
Q4 2020

Jan 27, 2021

SELL
$33.47 - $42.56 $302,736 - $384,955
-9,045 Reduced 1.46%
609,356 $22.4 Million
Q3 2020

Oct 21, 2020

BUY
$31.75 - $37.25 $323,500 - $379,540
10,189 Added 1.68%
618,401 $22.7 Million
Q2 2020

Jul 31, 2020

SELL
$30.12 - $36.54 $153,099 - $185,732
-5,083 Reduced 0.83%
608,212 $19.9 Million
Q1 2020

Apr 22, 2020

SELL
$27.03 - $38.62 $62,898 - $89,868
-2,327 Reduced 0.38%
613,295 $20 Million
Q4 2019

Jan 15, 2020

BUY
$32.92 - $37.36 $169,603 - $192,478
5,152 Added 0.84%
615,622 $24.1 Million
Q3 2019

Oct 16, 2019

SELL
$32.49 - $42.13 $290,850 - $377,147
-8,952 Reduced 1.45%
610,470 $21.9 Million
Q2 2019

Jul 11, 2019

BUY
$36.98 - $41.52 $40,567 - $45,547
1,097 Added 0.18%
619,422 $26.8 Million
Q1 2019

Apr 11, 2019

SELL
$37.5 - $41.2 $178,425 - $196,029
-4,758 Reduced 0.76%
618,325 $26.3 Million
Q4 2018

Jan 24, 2019

SELL
$38.47 - $43.86 $470,988 - $536,977
-12,243 Reduced 1.93%
623,083 $27.2 Million
Q3 2018

Oct 24, 2018

BUY
$34.47 - $41.81 $59,736 - $72,456
1,733 Added 0.27%
635,326 $28 Million
Q2 2018

Aug 10, 2018

BUY
$32.98 - $35.16 $175,585 - $187,191
5,324 Added 0.85%
633,593 $23 Million
Q1 2018

Apr 17, 2018

BUY
$31.91 - $37.02 $109,610 - $127,163
3,435 Added 0.55%
628,269 $22.3 Million
Q4 2017

Jan 19, 2018

BUY
$33.26 - $35.29 $64,291 - $68,215
1,933 Added 0.31%
624,834 $22.6 Million
Q3 2017

Oct 20, 2017

BUY
$31.0 - $34.15 $19.3 Million - $21.3 Million
622,901
622,901 $22.2 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $157B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Ingalls & Snyder LLC Portfolio

Follow Ingalls & Snyder LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ingalls & Snyder LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ingalls & Snyder LLC with notifications on news.